Oversee the timely order and shipment of comparative samples from various suppliers to partners and Clinical Research Centres (CROs) globally to assist in bioequivalence studies.
Responsible for release of the product by ensuring review of relevant audit trial of Manufacturing. Strong knowledge of cGMP, ICH guidelines, FDA regulations, and other relevant standards for biologics manufacturing.
About the Event The Indian Pharma Industry faces a myriad of challenges when it comes to ensuring the quality and compliance of computer software used in manufacturing processes. With stringent regulatory requirements, evolving technologies, and the increasing complexity of software systems, industry professionals are constantly seeking solutions to navigate these challenges effectively.
Knight Therapeutics Inc. specialty pharmaceutical company, announced today that Knight's New Drug Submission (NDS) for CREXONT® has been accepted for review by Health Canada.